JPS5262265A - Method - Google Patents

Method

Info

Publication number: JPS5262265A
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP51134735A

Other languages

English (en)

Other versions

JPS6228158B2 (ja

Inventor

Pauru Shiefuaado Kenesu

Henrii Ban Riinen Baaran

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pharmacia and Upjohn Co

Original Assignee

Upjohn Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-11-17

Filing date

1976-11-11

Publication date

1977-05-23

1976-11-11 Application filed by Upjohn Co filed Critical Upjohn Co

1977-05-23 Publication of JPS5262265A publication Critical patent/JPS5262265A/ja

1987-06-18 Publication of JPS6228158B2 publication Critical patent/JPS6228158B2/ja

Status Granted legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Electromechanical Clocks (AREA)
Electric Clocks (AREA)

JP51134735A 1975-11-17 1976-11-11 Method Granted JPS5262265A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/632,671 US4041055A (en)	1975-11-17	1975-11-17	Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes

Publications (2)

Publication Number	Publication Date
JPS5262265A true JPS5262265A (en)	1977-05-23
JPS6228158B2 JPS6228158B2 (ja)	1987-06-18

Family

ID=24536447

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
JP51134735A Granted JPS5262265A (en)	1975-11-17	1976-11-11	Method
JP61262903A Granted JPS6354391A (ja)	1975-11-17	1986-11-06	ステロイドの製法
JP61262901A Granted JPS6354393A (ja)	1975-11-17	1986-11-06	１７α−ヒドロキシステロイド及びその製法

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
JP61262903A Granted JPS6354391A (ja)	1975-11-17	1986-11-06	ステロイドの製法
JP61262901A Granted JPS6354393A (ja)	1975-11-17	1986-11-06	１７α−ヒドロキシステロイド及びその製法

Country Status (12)

Country	Link
US (1)	US4041055A (ja)
JP (3)	JPS5262265A (ja)
CH (2)	CH636362A5 (ja)
DE (1)	DE2649753C2 (ja)
FR (2)	FR2351997A1 (ja)
GB (4)	GB1531049A (ja)
HU (8)	HU174396B (ja)
IE (1)	IE44548B1 (ja)
IL (3)	IL50787A (ja)
MX (1)	MX4328E (ja)
NL (1)	NL170420C (ja)
PL (3)	PL116356B1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6354391A (ja) *	1975-11-17	1988-03-08	ジ　アツプジヨン　カンパニ−	ステロイドの製法

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4216159A (en) *	1978-05-25	1980-08-05	The Upjohn Company	Synthesis of 16-unsaturated pregnanes from 17-keto steroids
US4336200A (en) *	1980-01-31	1982-06-22	The Upjohn Company	17α-Acyloxy-5β-corticoids
FR2486947A1 (fr) *	1980-07-15	1982-01-22	Roussel Uclaf	Nouveaux derives steroides 20-isonitriles 17(20) insatures, leur procede de preparation et leur application a la preparation des steroides 17a-hydroxy 20-ceto
HU183397B (en) *	1981-04-16	1984-04-28	Richter Gedeon Vegyeszet	Process for preparing 17alpha-hydroxy-pregn-4-ene-3,20-dione derivatives
US4342702A (en) *	1981-05-18	1982-08-03	The Upjohn Company	Metallated halogenated acetylene corticoid synthesis
US4357279A (en) *	1981-05-18	1982-11-02	The Upjohn Company	Preparation of corticoids from 17-keto steroids
US4411835A (en) *	1981-05-18	1983-10-25	The Upjohn Company	Preparation of corticoids from 17-keto steroids
US4404142A (en) *	1981-05-18	1983-09-13	The Upjohn Company	Preparation of corticoids from 17-keto steroids
US4412955A (en) *	1981-05-18	1983-11-01	The Upjohn Company	Preparation of corticoids from 17-keto steroids
US4401599A (en) *	1981-05-18	1983-08-30	The Upjohn Company	Preparation of 21-halo steroids
US4383947A (en) *	1981-07-24	1983-05-17	The Upjohn Company	Introduction of a fluorine atom
US4524134A (en) *	1982-07-30	1985-06-18	The Upjohn Company	Process for preparing 1,2-dehydro steroids
DE3322120A1 (de) *	1982-07-30	1984-02-02	The Upjohn Co., 49001 Kalamazoo, Mich.	Verfahren zur umwandlung von 1,2-gesaettigten 3-ketosteroiden in 1,2-dehydrosteroide
EP0104054A3 (en) *	1982-09-20	1985-10-09	The Upjohn Company	16-methylene-steroids and their preparation
US4704358A (en) *	1982-10-25	1987-11-03	The Upjohn Company	Δ1 -dehydrogenation with heat or air-dried B. cyclooxidans
US4684610A (en) *	1983-03-15	1987-08-04	The Upjohn Company	Process for converting 1,2-saturated steroids to 1,2-dehydro steroids
US4749649A (en) *	1983-05-16	1988-06-07	The Upjohn Company	Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
US4618456A (en) *	1984-03-20	1986-10-21	The Upjohn Company	Ethynylation of 16-methyl-17-keto steroids
US4614621A (en) *	1984-04-20	1986-09-30	The Upjohn Company	Ethynylation of 16-methylene-17-keto steroids
US4548748A (en) *	1984-02-03	1985-10-22	The Upjohn Company	Cyanohydrin process
US4831131A (en) *	1984-02-03	1989-05-16	The Upjohn Company	11β,17α-Dihydroxy-17β-cyano-androstanes
US4500461A (en) *	1984-02-03	1985-02-19	The Upjohn Company	Cyanohydrin process
US4585590A (en) *	1984-02-03	1986-04-29	The Upjohn Company	Cyanohydrin process
US4530795A (en) *	1984-02-27	1985-07-23	The Upjohn Company	Process for preparation of 16 α-methyl corticoids from Δ16 -steroids
US4600538A (en) *	1984-08-02	1986-07-15	The Upjohn Company	Corticosteroids from 17-keto steroids via 20-cyano-Δ17 (20)-pregnanes
US4613463A (en) *	1984-11-01	1986-09-23	The Upjohn Company	Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid
US5380840A (en) *	1985-09-12	1995-01-10	The Upjohn Company	Triazinylpiperazinyl steroids
US5099019A (en) *	1985-09-12	1992-03-24	Upjohn Company	Amines useful in producing pharmaceutically active CNS compounds
USRE35053E (en) *	1985-09-12	1995-10-10	The Upjohn Company	Amines useful in producing pharmaceutically active CNS compounds
US4910191A (en) *	1988-06-28	1990-03-20	Merrell Dow Pharmaceuticals Inc.	19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
US5972922A (en) *	1990-06-11	1999-10-26	Alcon Laboratories, Inc.	Steroids which inhibit angiogenesis
JPH05507912A (ja) *	1990-06-11	1993-11-11	アルコン・ラボラトリーズ，インコーポレイテッド	血管形成を阻害するステロイド
JP3378245B2 (ja) *	1991-11-22	2003-02-17	アルコンラボラトリーズ，インコーポレイテッド	血管形成抑制性ステロイド
US20040023935A1 (en) *	2002-08-02	2004-02-05	Dey, L.P.	Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) *	2002-12-06	2004-06-10	Dey, L.P.	Stabilized albuterol compositions and method of preparation thereof
HU227112B1 (hu) *	2006-06-14	2010-07-28	Richter Gedeon Nyrt	Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz
EP2805720B1 (en)	2008-05-28	2019-08-07	ReveraGen BioPharma, Inc.	Non-hormonal steroid modulators of NF-KB for treatment of disease
EP2556083A4 (en)	2010-04-05	2013-12-04	Validus Biopharma Inc	NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
CN102477060B (zh) *	2010-11-22	2014-08-13	华润紫竹药业有限公司	甾体化合物及其制备方法和用途
HUE027821T2 (en)	2011-12-23	2016-11-28	Crystal Pharma Sau	A method for alkinylation of 16-substituted-17-ketosteroid derivatives
CN104628806A (zh) *	2012-01-19	2015-05-20	华润紫竹药业有限公司	甾体化合物及其制备方法和用途
CN106046099B (zh) *	2012-01-19	2018-03-16	华润紫竹药业有限公司	甾体化合物及其制备方法和用途
CN102702296B (zh) *	2012-06-19	2014-09-03	山东诚创医药技术开发有限公司	环-3,20-双(1,2-亚乙基缩醛)-17α-羟基-17β-乙酰基-雌甾-5(10),9(11)-二烯-3-酮的制备方法
CN102942612A (zh) *	2012-10-30	2013-02-27	四川大学	一种合成醋酸乌利司他的新方法
WO2014067127A1 (zh) *	2012-11-02	2014-05-08	Huang Yunsheng	一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法
CN103145788B (zh) *	2013-03-25	2015-08-19	浙江仙琚制药股份有限公司	醋酸优力司特关键中间体的制备方法
WO2017004205A1 (en)	2015-06-29	2017-01-05	Reveragen Biopharma, Inc.	NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE
CN105001294A (zh) *	2015-07-29	2015-10-28	宝鸡康乐生物科技有限公司	一种妊娠素的合成方法
CN105153261B (zh) *	2015-10-08	2017-12-05	浙江仙居君业药业有限公司	一种炔孕酮的合成方法
CN106986911B (zh) *	2017-03-23	2019-05-10	湖南玉新药业有限公司	地塞米松关键中间体联烯亚砜物的制备方法
CN106986908B (zh) *	2017-03-23	2019-05-10	湖南玉新药业有限公司	倍他米松的制备方法
US11382922B2 (en)	2019-03-07	2022-07-12	Reveragen Biopharma, Inc.	Aqueous oral pharmaceutical suspension compositions
CN112175035A (zh) *	2020-09-08	2021-01-05	山东斯瑞药业有限公司	一种倍他米松重排物的制备方法及倍他米松重排物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3499016A (en) *	1958-08-04	1970-03-03	Upjohn Co	6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
US3499013A (en) *	1968-11-04	1970-03-03	Searle & Co	3-oxygenated 21beta-hydrocarbonsulfonyl-pregna-17(20),20-dienes,dehydro and 19-nor derivatives thereof and intermediates thereto
FR2150216A1 (en) *	1971-08-20	1973-04-06	Syntex Corp	17-vinylidene steroids - inters for progesterone derivs
US3992422A (en) *	1975-08-14	1976-11-16	Schering Corporation	Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes
US4041055A (en) *	1975-11-17	1977-08-09	The Upjohn Company	Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes

1975
- 1975-11-17 US US05/632,671 patent/US4041055A/en not_active Expired - Lifetime
1976
- 1976-10-04 MX MX764952U patent/MX4328E/es unknown
- 1976-10-27 IL IL50787A patent/IL50787A/xx unknown
- 1976-10-29 DE DE2649753A patent/DE2649753C2/de not_active Expired
- 1976-11-02 GB GB9336/78A patent/GB1531049A/en not_active Expired
- 1976-11-02 GB GB9335/78A patent/GB1531048A/en not_active Expired
- 1976-11-02 GB GB45413/76A patent/GB1531047A/en not_active Expired
- 1976-11-02 GB GB9337/78A patent/GB1531050A/en not_active Expired
- 1976-11-03 CH CH1388676A patent/CH636362A5/fr not_active IP Right Cessation
- 1976-11-08 NL NLAANVRAGE7612364,A patent/NL170420C/xx not_active IP Right Cessation
- 1976-11-11 JP JP51134735A patent/JPS5262265A/ja active Granted
- 1976-11-16 PL PL1976214253A patent/PL116356B1/pl unknown
- 1976-11-16 PL PL1976215854A patent/PL119050B1/pl unknown
- 1976-11-16 PL PL1976193723A patent/PL116459B1/pl unknown
- 1976-11-16 FR FR7634507A patent/FR2351997A1/fr active Granted
- 1976-11-17 HU HU76UO130A patent/HU174396B/hu unknown
- 1976-11-17 HU HU76UO127A patent/HU178128B/hu unknown
- 1976-11-17 IE IE2537/76A patent/IE44548B1/en unknown
- 1976-11-17 HU HU812029A patent/HU188067B/hu unknown
- 1976-11-17 HU HU76UO158A patent/HU178129B/hu unknown
- 1976-11-17 HU HU76UO157A patent/HU177914B/hu unknown
- 1976-11-17 HU HU@@A patent/HU173541B/hu unknown
- 1976-11-17 HU HU812028A patent/HU188066B/hu unknown
- 1976-11-17 HU HU76UO129A patent/HU173670B/hu unknown
1977
- 1977-08-05 FR FR7724254A patent/FR2366310A1/fr active Granted
1979
- 1979-10-23 IL IL58539A patent/IL58539A0/xx unknown
- 1979-10-23 IL IL58540A patent/IL58540A0/xx unknown
1980
- 1980-12-03 CH CH894180A patent/CH630394A5/de not_active IP Right Cessation
1986
- 1986-11-06 JP JP61262903A patent/JPS6354391A/ja active Granted
- 1986-11-06 JP JP61262901A patent/JPS6354393A/ja active Granted

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6354391A (ja) *	1975-11-17	1988-03-08	ジ　アツプジヨン　カンパニ−	ステロイドの製法
JPS6354393A (ja) *	1975-11-17	1988-03-08	ジ　アツプジヨン　カンパニ−	１７α−ヒドロキシステロイド及びその製法
JPH0113719B2 (ja) *	1975-11-17	1989-03-07	Upjohn Co
JPH0113718B2 (ja) *	1975-11-17	1989-03-07	Upjohn Co

Also Published As

Publication number	Publication date
GB1531047A (en)	1978-11-01
IE44548L (en)	1977-05-17
IE44548B1 (en)	1981-12-30
PL116356B1 (en)	1981-06-30
JPS6354391A (ja)	1988-03-08
HU173670B (hu)	1979-07-28
JPS6354393A (ja)	1988-03-08
HU178128B (en)	1982-03-28
GB1531048A (en)	1978-11-01
NL7612364A (nl)	1977-05-20
CH636362A5 (de)	1983-05-31
FR2351997B1 (ja)	1980-11-14
JPH0113719B2 (ja)	1989-03-07
GB1531050A (en)	1978-11-01
PL116459B1 (en)	1981-06-30
HU188066B (en)	1986-03-28
HU177914B (en)	1982-01-28
DE2649753C2 (de)	1982-08-19
HU188067B (en)	1986-03-28
IL50787A (en)	1983-06-15
HU178129B (en)	1982-03-28
PL214253A1 (ja)	1980-01-14
JPS6228158B2 (ja)	1987-06-18
GB1531049A (en)	1978-11-01
MX4328E (es)	1982-03-25
IL58539A0 (en)	1980-01-31
FR2351997A1 (fr)	1977-12-16
FR2366310B1 (ja)	1980-11-14
US4041055A (en)	1977-08-09
FR2366310A1 (fr)	1978-04-28
PL215854A1 (ja)	1980-04-21
HU173541B (hu)	1979-06-28
PL119050B1 (en)	1981-11-30
IL50787A0 (en)	1976-12-31
DE2649753A1 (de)	1977-05-26
IL58540A0 (en)	1980-01-31
NL170420C (nl)	1982-11-01
HU174396B (hu)	1979-12-28
PL193723A1 (ja)	1980-01-28
CH630394A5 (de)	1982-06-15
NL170420B (nl)	1982-06-01
JPH0113718B2 (ja)	1989-03-07

Publication	Publication Date	Title
JPS5282510A (en)	1977-07-09	Copyypicture method
JPS5262265A (en)	1977-05-23	Method
JPS51142035A (en)	1976-12-07	Adhering method
JPS51143603A (en)	1976-12-10	Hydroformilation method
ZM7076A1 (en)	1978-01-23	Process
JPS51133559A (en)	1976-11-19	Falseetwisting method
JPS5236678A (en)	1977-03-22	Dihydroxadiazinon preparation method thereof
GB1553619A (en)	1979-09-26	Datarecording method
JPS51115458A (en)	1976-10-12	Method
JPS5262210A (en)	1977-05-23	Hydroformilation method
JPS5277001A (en)	1977-06-29	Combining isomerizationnalkylation method
PT65369B (en)	1978-01-10	Reduction process
JPS525353A (en)	1977-01-17	Falseetwisting method
JPS5264113A (en)	1977-05-27	Antiiearthquake method
JPS5221232A (en)	1977-02-17	Ionnetching method
JPS51146340A (en)	1976-12-15	Satining method
JPS5227851A (en)	1977-03-02	Falseetwisting method
JPS5265975A (en)	1977-05-31	Deoderization method
JPS51116027A (en)	1976-10-13	Constructing method
GB1549646A (en)	1979-08-08	Gelatin-hardening process
ZA763906B (en)	1977-05-25	Reduction process
JPS527335A (en)	1977-01-20	Silverrelectroplating method
JPS51130399A (en)	1976-11-12	Marcerizing method
JPS5275466A (en)	1977-06-24	Unittcost setting method
JPS5251371A (en)	1977-04-25	Nitroaminopyridine preparation method